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EDITORIAL
The glomerular tip lesion: What does it really mean?
Since its initial description by Howie and Brewer in 1984
[1], the glomerular tip lesion (GTL) has been a source
of both confusion and controversy. As discussed below,
much of the confusion relates to how the GTL is defined.
The controversy seems more complex, however; once the
confusion over terminology is resolved, it appears to boil
down to two major issues: first, what is the relationship
of the GTL to primary focal segmental glomeruloscle-
rosis (FSGS), and second, what are the therapeutic im-
plications of a diagnosis of GTL? While the resolution
of the first of these issues will likely have to await more
extensive molecular characterization of podocyte abnor-
malities in GTL, various histologic forms of FSGS, and
minimal change disease (MCD), a reasonable approach
to the second issue appears possible on the basis of our
current knowledge, including the study of Howie et al [2]
in this issue of Kidney International.
In their 1984 paper reporting 20 cases of GTL, Howie
and Brewer [1] described a lesion involving a small area
of the glomerular tuft that was always situated “adja-
cent to the origin of the proximal convoluted tubule,
with adhesion to Bowman’s capsule.” They also noted
that the rest of the glomerular tuft “appears normal by
light microscopy but shows foot-process fusion by elec-
tron microscopy,” the latter consistent with the presen-
tation of all of their patients with proteinuria of 3.5 to
30.6 g/day. Later, however, the definition of GTL became
expanded to include lesions observed in the presence of
other glomerular abnormalities and/or involving larger
portions of the glomerular tuft. Howie [3] reported mor-
phologic changes at the tubular origin resembling those in
his original 20 cases of GTL in membranous nephropathy
and other glomerulopathies characterized by persistent
proteinuria. Howie [3] argued that these “tip changes”
represent a secondary manifestation of protein leakage
from the glomerulus, and that the prognosis in such cases
is determined by the underlying glomerular pathology
and not the tip changes. A corollary of this is that tip
changes in the absence of other histologic abnormalities,
such as in the original 20 cases of GTL, can be regarded as
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representing a variant of MCD, and indeed, tip changes
were later demonstrated in autopsy specimens of kidneys
from children with MCD who died from infections in the
preantibiotic, precorticosteroid era [4].
Most recently, the term GTL has been used to define
a specific histologic variant of FSGS. A pathologic classi-
fication of FSGS proposed by four leading renal pathol-
ogists (the “Columbia Classification; ” [5]) defines the
glomerular tip variant of FSGS by the presence of one or
more segmental lesions involving the outer 25% of the
glomerular tuft next to the origin of the proximal tubule,
in the absence of perihilar sclerosis or collapsing FSGS.
Stokes et al [6] recently compared 47 cases of GTL, de-
fined as above, with 61 cases of MCD and 50 cases of
FSGS not of the glomerular tip or collapsing types. Sim-
ilar to findings of Howie and Brewer [1] and Beaman
et al [7] in the original cases of GTL that were defined
more stringently, Stokes et al [6] found that GTL patients
closely resembled those with MCD with respect to high
incidence (∼90%) of nephrotic syndrome and paucity of
chronic tubulointerstitial changes on the biopsy. Further-
more, as with earlier studies [1, 7, 8], more than 70% of
GTL patients of Stokes et al [6] showed a reduction in
proteinuria in response to treatment with steroids alone
or plus a cytotoxic agent, with 59% having complete re-
mission of proteinuria at a mean follow-up of 21.6 months.
In this issue of Kidney International, Howie et al [2]
follow both the clinical and pathologic progression of seg-
mental glomerular lesions associated with the nephrotic
syndrome, including lesions limited to the tubular origin
as in the original definition of GTL. The study presents
three major findings relevant to the relationship of the
GTL to FSGS and to MCD. First, histologic progression
from GTL to FSGS with segmental lesions involving sites
removed from the tubular origin [FSGS (NOS) per the
Columbia Classification] is more than a rare occurrence.
Seventeen of 24 patients with an initial renal biopsy show-
ing GTL and one or more subsequent specimens (biopsy
or autopsy) had findings of FSGS (NOS) on at least one
subsequent specimen, while only 7 patients had GTL on
all specimens. While these findings are clearly skewed by
the fact that patients undergoing a second biopsy had per-
sistent or relapsing proteinuria, they nonetheless suggest
that progression of GTL to FSGS (NOS) is not uncom-
mon. Second, GTL represents an early histologic finding
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in patients who develop FSGS, although it remains un-
clear whether the GTL in these cases represents a mani-
festation of the FSGS itself or a nonspecific response to
proteinuria occurring during the interval between initial
podocyte injury and development of diagnostic segmen-
tal scars. Four patients who lost their native kidneys due
to FSGS developed recurrent nephrotic syndrome in a
total of 7 renal allografts; initial biopsies of 6 of these
grafts showed GTL, with FSGS (NOS) seen on subse-
quent specimens from 2 of the grafts. Third, the clinical
behavior of GTL that does not progress to FSGS resem-
bles that of MCD, with response of proteinuria to steroids
and/or other immunosuppressive agents and long-term
renal survival [2].
Thus, it appears that GTL, whether defined by the
original definition of Howie and Brewer [1] or the less
restrictive one proposed in the Columbia Classification
[5], represents a heterogeneous group of lesions that
can behave like MCD or FSGS. Routine light and elec-
tron microscopy cannot distinguish good actors from
bad, although in the future, immunohistologic studies of
podocyte proteins whose expression is altered in FSGS
but not MCD, or vice versa, may prove helpful in this
regard. For now, only the response to treatment can reli-
ably predict the outcome of the GTL, much as is the case
with classic (NOS) and collapsing variants of FSGS [9].
Chun et al [9] found that among 11 nephrotic adults with
a diagnosis of GTL, none of 7 who attained a complete
or partial remission of proteinuria in response to steroid
therapy developed end-stage renal disease (ESRD) after
up to 10 years of follow-up, while 3 of 4 patients (including
1 of 2 who were not treated) not entering remission devel-
oped ESRD within 30 months. Thus, it would presently
appear that the best advice for a nephrologist caring for a
patient with a renal biopsy diagnosis of GTL, whether de-
fined according to Howie and Brewer [1] or the Columbia
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